Lv34
240 积分 2026-01-07 加入
Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity
10小时前
待确认
Harnessing Surface Hydrophilicity of Inhalable Nanoparticles for Precision Delivery of Glucagon-like Peptide-1 Receptor Agonists or Anti-Asthmatic Therapeutics
8天前
已完结
Charge-based supramolecular peptide nanocomplexes for oral delivery via transporter-driven endocytosis
8天前
已完结
Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage
9天前
已完结
Lesional Macrophage‐Targeted Nanomedicine Regulating Cholesterol Homeostasis for the Treatment of Atherosclerosis
16天前
已完结
Advances in β‐Cyclodextrin‐Driven Self‐Healing Materials: Molecular Design and Multifunctional Applications
25天前
已完结
Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis
26天前
已完结
Cyclodextrins as versatile supramolecular building block in nanoscale drug delivery systems for precise tumor chemotherapy
26天前
已完结
Tailoring renal-clearable zwitterionic cyclodextrin for colorectal cancer-selective drug delivery
26天前
已完结
Zwitterionic Biomaterials
28天前
已完结
皖公网安备34019202002308
